International Clinical Trial: Mechanistic Study on the Interplay Between circATIC and miR-10b-3p in Affecting Cell Proliferation, Apoptosis, and Endoplasmic Reticulum Stress-Related Protein Expression in Psoriasis

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115815) titled 'Mechanistic Study on the Interplay Between circATIC and miR-10b-3p in Affecting Cell Proliferation, Apoptosis, and Endoplasmic Reticulum Stress-Related Protein Expression in Psoriasis' on Dec. 31, 2025.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Shaanxi Provincial People's Hospital

Condition: Psoriasis

Intervention: Healthy control group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Healthy control group:30;Psoriasis patient group:30;

Countries of Recruitment: China

To know more, visit https://www...